Form 8-K - Current report:
SEC Accession No. 0001104659-20-128482
Filing Date
2020-11-23
Accepted
2020-11-23 16:33:31
Documents
3
Period of Report
2020-11-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2027048d18_8k.htm 8-K 21657
2 EXHIBIT 3.1 tm2027048d18_ex3-1.htm EX-3.1 39686
3 EXHIBIT 3.2 tm2027048d18_ex3-2.htm EX-3.2 199246
  Complete submission text file 0001104659-20-128482.txt   261733
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 201338051
SIC: 2834 Pharmaceutical Preparations